-
Price Momentum
LKFT is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of LKFT shares has decreased $0.36 since the market last closed. This is a 1.25% drop.
-
Last closed at $28.55.
The stock has since dropped $0.08 in pre-market trading.
Key terms
About LKFT
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
-
Market cap: $1.65B
A market capitalization between $300 million and $2 billion places LKFT in the small capitalization category.
Key terms
Smart score
Latest LKFT news
No recent press releases are available for LKFT
LKFT Financials
-
Total revenue: $1.25B (1Y), $14.08M (Q2)
Total Revenue increased 320.99% since last year and increased 85.7% since last quarter.
-
Net income: $362.14M (1Y), $2.26M (Q2)
Net Income increased 351.92% since last year and decreased 86.09% since last quarter.
-
Earnings per share: $5.50 (1Y), $0.04 (Q2)
EPS increased 351.91% since last year and decreased 85.5% since last quarter.
Key terms
LKFT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LKFT Competitors
-
How competitors are chosen
LKFT's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.65B
A market capitalization between $300 million and $2 billion places LKFT in the small capitalization category.
